These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 30200779)

  • 21. What's new in the treatment of serious MRSA infection?
    Holmes NE; Howden BP
    Curr Opin Infect Dis; 2014 Dec; 27(6):471-8. PubMed ID: 25211361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibacterial Activity of Tedizolid, a Novel Oxazolidinone Against Methicillin-Resistant
    Hasannejad-Bibalan M; Mojtahedi A; Biglari H; Halaji M; Sedigh Ebrahim-Saraie H
    Microb Drug Resist; 2019 Nov; 25(9):1330-1337. PubMed ID: 31290721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Network meta-analysis and pharmacoeconomic evaluation of antibiotics for the treatment of patients infected with complicated skin and soft structure infection and hospital-acquired or ventilator-associated penumonia.
    Zhang Y; Wang Y; Van Driel ML; McGuire TM; Zhang T; Dong Y; Liu Y; Liu L; Hao R; Cao L; Xing J; Dong Y
    Antimicrob Resist Infect Control; 2019; 8():72. PubMed ID: 31080587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the phase 3 ESTABLISH trials of tedizolid versus linezolid in acute bacterial skin and skin structure infections.
    Shorr AF; Lodise TP; Corey GR; De Anda C; Fang E; Das AF; Prokocimer P
    Antimicrob Agents Chemother; 2015 Feb; 59(2):864-71. PubMed ID: 25421472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative efficacy of human-simulated epithelial lining fluid exposures of tedizolid, linezolid and vancomycin in neutropenic and immunocompetent murine models of staphylococcal pneumonia.
    Kidd JM; Abdelraouf K; Nicolau DP
    J Antimicrob Chemother; 2019 Apr; 74(4):970-977. PubMed ID: 30561650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the microbiological efficacy of tedizolid and linezolid in acute bacterial skin and skin structure infections: pooled data from phase 3 clinical trials.
    Corey R; Moran G; Goering R; Bensaci M; Sandison T; De Anda C; Prokocimer P
    Diagn Microbiol Infect Dis; 2019 Jul; 94(3):277-286. PubMed ID: 30940414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical trial results with linezolid, an oxazolidinone, in the treatment of soft tissue and postoperative gram-positive infections.
    Wilson SE
    Surg Infect (Larchmt); 2001; 2(1):25-35. PubMed ID: 12594878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tedizolid is a promising antimicrobial option for the treatment of Staphylococcus aureus infections in cystic fibrosis patients.
    Roch M; Varela MC; Taglialegna A; Rosato AE
    J Antimicrob Chemother; 2020 Jan; 75(1):126-134. PubMed ID: 31617901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and Efficacy of Oral and/or Intravenous Tedizolid Phosphate From a Randomized Phase 3 Trial in Adolescents With Acute Bacterial Skin and Skin Structure Infections.
    Bradley JS; Antadze T; Ninov B; Tayob MS; Broyde N; Butterton JR; Chou MZ; De Anda CS; Kim JY; Sears PS
    Pediatr Infect Dis J; 2021 Mar; 40(3):238-244. PubMed ID: 33395210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An in vitro evaluation of the efficacy of tedizolid: implications for the treatment of skin and soft tissue infections.
    Delpech P; ALeryan M; Jones B; Gemmell C; Lang S
    Diagn Microbiol Infect Dis; 2018 May; 91(1):93-97. PubMed ID: 29452993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic drug evaluation of tedizolid for the treatment of skin infections.
    McBride D; Krekel T; Hsueh K; Durkin MJ
    Expert Opin Drug Metab Toxicol; 2017 Mar; 13(3):331-337. PubMed ID: 28140693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysis.
    Bounthavong M; Hsu DI
    Curr Med Res Opin; 2010 Feb; 26(2):407-21. PubMed ID: 20001574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New antibiotics in the management of acute bacterial skin and skin structure infections.
    Gleghorn K; Grimshaw E; Kelly EK
    Skin Therapy Lett; 2015; 20(5):7-9. PubMed ID: 26382907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Vitro Activities of Tedizolid and Linezolid against Gram-Positive Cocci Associated with Acute Bacterial Skin and Skin Structure Infections and Pneumonia.
    Chen KH; Huang YT; Liao CH; Sheng WH; Hsueh PR
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6262-5. PubMed ID: 26248355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lipopeptides and oxazolidinones--novel antibiotics in MRSA infection treatment].
    Pangercić A; Bukovski-Simonoski S; Barsić B
    Lijec Vjesn; 2010; 132 Suppl 1():11-3. PubMed ID: 20715711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
    Puzniak LA; Morrow LE; Huang DB; Barreto JN
    Clin Ther; 2013 Oct; 35(10):1557-70. PubMed ID: 24011955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of oxazolidinones (linezolid or tedizolid) for the treatment of breast infections. A case series from a tertiary referral hospital.
    Kirkegaard C; Parramón-Teixidó CJ; Morales-Comas C; Clemente Bautista S; Rivero Deniz J; Fernández-Hidalgo N
    Infection; 2024 Aug; 52(4):1585-1593. PubMed ID: 38691231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid.
    Bassetti M; Baguneid M; Bouza E; Dryden M; Nathwani D; Wilcox M
    Clin Microbiol Infect; 2014 Apr; 20 Suppl 4():3-18. PubMed ID: 24580738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Linezolid versus vancomycin for MRSA skin and soft tissue infections (systematic review and meta-analysis).
    Dodds TJ; Hawke CI
    ANZ J Surg; 2009 Sep; 79(9):629-35. PubMed ID: 19895519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of tedizolid against methicillin-resistant Staphylococcus aureus and Peptostreptococcus anaerobius in thigh mixed-infection mouse model.
    Yamagishi Y; Mikamo H; Kato H; Nishiyama N; Asai N; Koizumi Y; Sakanashi D; Suematsu H; Matsuura K; Hagihara M
    J Infect Chemother; 2017 Jun; 23(6):368-373. PubMed ID: 28343752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.